Kailera Therapeutics, Inc.
NASDAQKailera Therapeutics entered the week fielding a wave of analyst initiations — four in a single day — even as the stock pulled back from its IPO-era highs. The story of this week is one of institutional conviction meeting post-IPO gravity. Four major firms — JP Morgan, Evercore ISI, Jefferies, and Leerink Partners — all initiated coverage on May 12 with bullish ratings. Jefferies…
Snapshot as of 28 Jun 2026
Kailera Therapeutics entered the week fielding a wave of analyst initiations — four in a single day — even as the stock pulled back from its IPO-era highs. The story of this week is one of institutional conviction…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KLRA — free to start on ORTEX.
Sign up for free →Open KLRA on ORTEX